UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000048459
Receipt number R000055226
Scientific Title Pre- and post-comparative pilot study of the feasibility and safety of Internet-delivered cognitive behavioral therapy for irritable bowel syndrome
Date of disclosure of the study information 2022/10/01
Last modified on 2023/09/04 17:52:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Remote Self-guided and Efficacious cognitive-behavioral Therapy for irritable bowel syndrome(ReSET):a pilot study

Acronym

Cognitive Behavioral Therapy Pilot Study for Irritable Bowel Syndrome (Reset Program)

Scientific Title

Pre- and post-comparative pilot study of the feasibility and safety of Internet-delivered cognitive behavioral therapy for irritable bowel syndrome

Scientific Title:Acronym

Pilot study on feasibility and safety of iCBT for IBS

Region

Japan


Condition

Condition

irritable bowel syndrome

Classification by specialty

Hepato-biliary-pancreatic medicine Psychosomatic Internal Medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

feasibility

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Irritable bowel syndrome severity and quality of life

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

ICT-based Cognitive Behavioral Therapy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

18 years of age or older.
Diagnosed with IBS at a medical facility and treated with medication for at least 3 months
Have residual symptoms of at least mild (IBS-SSS more than 75 points)
Meet Rome III or Rome IV IBS diagnostic criteria
Have regular access to the Internet
Able to read, write, and communicate in Japanese
Voluntary consent to participate in the study

Key exclusion criteria

Currently receiving other structured psychotherapy at the time of enrollment or plan to do so during the intervention period
Currently receiving psychiatric or psychosomatic treatment and deemed by the attending physician to be ineligible for participation in the study
Meet the diagnostic criteria for major depression on the PHQ-9 at the time of enrollment, or have "more than half of a week" of suicidal ideation on item 9 of the PHQ-9 at the time of enrollment
Pregnant women
Those who have been treated or are undergoing treatment for organic diseases of the abdomen or other parts of the body.
Anyone who is judged to be unsuitable for this study

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Shino
Middle name
Last name Kikuchi

Organization

Kyoto University Graduate School of Medicine

Division name

Faculty of Medicine

Zip code

6068315

Address

Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501 JAPAN

TEL

+81750757539491

Email

shino_k@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Shino
Middle name
Last name Kikuchi

Organization

Kyoto University Graduate School of Medicine

Division name

Faculty of Medicine

Zip code

6068315

Address

+81750757539491

TEL

+81750757539491

Homepage URL


Email

suciri117@gmail.com


Sponsor or person

Institute

Kyoto University

Institute

Department

Personal name



Funding Source

Organization

Kyoto University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto University Graduate School and Faculty of Medicine, Ethics Committee

Address

Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, JAPAN

Tel

+81757534680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

132

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 07 Month 26 Day

Date of IRB

2022 Year 10 Month 13 Day

Anticipated trial start date

2022 Year 10 Month 15 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete

2023 Year 03 Month 31 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 07 Month 26 Day

Last modified on

2023 Year 09 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000055226


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name